Thursday, 30 July 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 30 July 2026
News

Aussie boss roasted on LinkedIn

Posted 30 July 2026 AM

The new Australian CEO of GSK Luke Miels yesterday brazenly unveiled a three-year costing-saving program just six months into the job, but it was his much more low-key announcement to relocate the company's R&D headquarters, that has sparked a fierce response on LinkedIn.

GSK said it would establish a new flagship R&D Centre on the UK's Cambridge Biomedical Campus, closing its historic R&D hub in Stevenage.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (19)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (3)

Devices (1)

Other (12)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.